GGrantIndex
← Leaderboards

Southern Illinois University Sch Of Med

Springfield, IL

Compare ↔
$91,557,808
Total funding
111
Grants

Funding over time

peak $11M · FY2005–25
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$91,557,808 · 111

By mechanism

R01$64,807,691 · 41
P01$8,448,555 · 6
R21$5,010,640 · 13
R15$4,243,680 · 12
S10$1,490,596 · 9
K01$1,462,889 · 3

Investigators at Southern Illinois University Sch Of Med

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Erin R Hascup$7,159,9182 gr2Ben D Richardson$1,929,3762 gr

All-Time

Most funded here, all years

1Kounosuke Watabe$10,019,1388 gr2Donald M Caspary$8,781,9954 gr3Laura Q Rogers$7,306,3925 gr4Erin R Hascup$7,159,9182 gr5Leonard P Rybak$5,077,8622 gr6Gregory J Brewer$4,944,2174 gr7Liou Sun$4,429,1166 gr8Virginia Eunice Kimonis$4,384,13410 gr

Largest grants

The Somatotropic Axis and Health Aging: A Search for Mechanisms$1,772,246
P01 · FY2012 · AG
The Somatotropic Axis and Health Aging: A Search for Mechanisms$1,756,565
P01 · FY2011 · AG
The Somatotropic Axis and Health Aging: A Search for Mechanisms$1,661,073
P01 · FY2010 · AG
The Somatotropic Axis and Health Aging: A Search for Mechanisms$1,622,223
P01 · FY2009 · AG
The Somatotropic Axis and Health Aging: A Search for Mechanisms$1,614,157
P01 · FY2013 · AG
Cellular senescence, inflammation and neurotransmission in Alzheimer's disease$774,630
R01 · FY2020 · AG
Enhancing physical activity after breast cancer diagnosis: randomized trial$717,182
R01 · FY2009 · CA
Cellular senescence, inflammation and neurotransmission in Alzheimer's disease$708,790
R01 · FY2018 · AG
Enhancing physical activity after breast cancer diagnosis: randomized trial$682,529
R01 · FY2010 · CA
Cellular senescence, inflammation and neurotransmission in Alzheimer's disease$668,790
R01 · FY2021 · AG
Cellular senescence, inflammation and neurotransmission in Alzheimer's disease$668,790
R01 · FY2022 · AG
Cellular senescence, inflammation and neurotransmission in Alzheimer's disease$668,790
R01 · FY2019 · AG
Enhancing physical activity after breast cancer diagnosis: randomized trial$667,631
R01 · FY2011 · CA
Coding in Auditory Neurons: Effects of Amino Acids$643,304
R01 · FY2023 · DC
Glutamate neurotransmission in Alzheimer's disease progression$615,085
R01 · FY2018 · AG
Glutamate neurotransmission in Alzheimer's disease progression$583,085
R01 · FY2019 · AG
Glutamate neurotransmission in Alzheimer's disease progression$583,085
R01 · FY2022 · AG
Glutamate neurotransmission in Alzheimer's disease progression$583,085
R01 · FY2021 · AG
Glutamate neurotransmission in Alzheimer's disease progression$583,085
R01 · FY2020 · AG
Optimizing D-methionine (D-met) Pre-loading and Rescue Dosing Through Functional and Biomarker Measures$574,563
R01 · FY2017 · DC